Dapagliflozin and metformin "''"''"'

Dapagliflozin and metformin 
GLIDAPAFLOZIN M  are two distinct medications commonly used in the management of type 2 diabetes. They belong to different classes of antidiabetic drugs and work through different mechanisms to help control blood sugar levels.
Dapagliflozin:
Class and Mechanism of Action:
Class: Sodium-glucose co-transporter 2 (SGLT2) inhibitor.
Inhibits SGLT2, a protein in the kidneys responsible for reabsorbing glucose. By blocking this protein, dapagliflozin promotes the excretion of excess glucose in the urine, leading to reduced blood glucose levels.
Metformin:
Class and Mechanism of Action:
Class: Biguanide.
Mechanism of Action: Reduces glucose production in the liver, improves insulin sensitivity in peripheral tissues, and decreases intestinal glucose absorption. Metformin does not stimulate insulin release from the pancreas.
GLIDAPAFLOZIN M  are sometimes prescribed together as part of combination therapy to achieve better glycemic control.
Combining medications with different mechanisms of action can have additive effects, addressing multiple aspects of glucose regulation.
GLIDAPAFLOZIN M  combination therapy can lead to improved glycemic control, weight loss, and a lower risk of hypoglycemia compared to some other antidiabetic medications.
Each medication has its own dosing schedule and administration instructions.
Dapagliflozin is typically taken orally once a day.
Metformin is also taken orally, usually with meals, and may be prescribed once or multiple times a day, depending on the formulation.
For further information please contact:
info@sterispharma.com
Order Now - https://www.sterisonline.com/product/glidapaflozin-m-5-500-133424